{"id":"W3203942868","doi":"10.1007/s41669-021-00300-8","title":"Cost-Effectiveness Analysis of Evolocumab for the Treatment of Dyslipidemia in the Kingdom of Saudi Arabia","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Evolocumab; Medicine; Ezetimibe; Familial hypercholesterolemia; Dyslipidemia; Statin; Internal medicine; Quality-adjusted life year; Alirocumab; Cost effectiveness; Cholesterol; Disease; Lipoprotein","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002155097,0.0001137873,0.000951387,0.00009164144,0.00004046492,0.0000120706,0.0002705004,0.00004151361,0.00008945337],"category_scores_gemma":[0.00006937576,0.0000682609,0.0005393949,0.0003814038,0.00005795372,0.00005501674,0.00005404502,0.00006713874,7.190214e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001834508,"about_ca_system_score_gemma":0.0003142213,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002621559,"about_ca_topic_score_gemma":0.0004295169,"domain_scores_codex":[0.9987509,0.0002653355,0.0004937162,0.0002219956,0.000116607,0.0001514143],"domain_scores_gemma":[0.9980753,0.0008131991,0.0002548712,0.0006805118,0.0001372075,0.00003887705],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.008283414,0.005899205,0.2227013,0.002521927,0.06654343,0.00003765525,0.008066596,0.04457593,0.02057586,0.005838801,0.001125617,0.6138303],"study_design_scores_gemma":[0.03022382,0.001384534,0.5251201,0.000232654,0.02363998,0.00001856814,0.002070939,0.0352432,0.2816463,0.0004127377,0.09963451,0.0003726939],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920399,0.002347844,0.0006024463,0.0007835559,0.0001194045,0.003516259,0.0001603356,0.000002161396,0.0004280615],"genre_scores_gemma":[0.9976152,0.001119936,0.0002421874,0.0002712325,0.00007338559,0.0005813323,0.00005460185,0.0000123552,0.00002972416],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6134576,"threshold_uncertainty_score":0.396303,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1132914764465246,"score_gpt":0.427569372084309,"score_spread":0.3142778956377844,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}